Adrian Newman-Tancredi​

Adrian Newman-Tancredi has more than thirty years in neuroscience research and drug discovery & development, and consults on neuroscience and biotech management.

Before joining Neurolixis he was Director of Neurobiology and Project Manager at Pierre Fabre Laboratories, leading programs that identified and characterized novel antipsychotics, antidepressants, and analgesics, and earlier led a molecular pharmacology group. Ask him about preclinical models, serotonin receptors, drug discovery and early clinical development, or biopharmaceutical strategy and management.